TrialThe oncologist2025

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

Kathryn E Beckermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.